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strated a proapoptotic transcriptome. In vitro, ischemic
AKI activated apoptosis (FasL,Dapk1,Bcl10) and TNF
family (TNFR1,TNFR2,TNF) genes, caspase-3 (100 
1.1 vs 106.5  0.8, P  .00325), and PARP (10  3.5 vs
61.8  20.5, P  .047) vs sham. Etanercept inhibited
RLMVEC inflammatory genes (E-Selectin, ICAM-1, IL-6,
RhoB), caspase-3 activity (100  0.9 vs 102  0.5, P 
.096) and PARP activity (10  2.3 vs 10.9  2.2, P 
.783) vs vehicle during ischemic AKI.
Conclusions: Ischemic AKI drives a proinflammatory
and proapoptotic lung EC transcriptome with TNFR1-
dependent apoptosis. Further study of EC-specific mecha-
nisms of kidney-lung crosstalk during AKI may identify
potential therapeutic targets.
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Objectives: Surgical bypass and dialysis access cre-
ation are common procedures performed in diabetic
patients. Only 45% of patients have autologous vascular
tissue available for use as a conduit for these procedures.
We have developed an alternative conduit composed of a
vascular scaffold seeded with autologous adipose-derived
stem cells (ASC) differentiated into endothelial cells
(EC) to create a non-thrombogenic lumen. Herein, we
examine ASC from diabetic (DM) versus non-diabetics
(NDM) patients in terms of isolation efficiency, prolifer-
ation, commitment towards EC lineage, and seeding
onto a vascular scaffold.
Methods: ASC were isolated from peri-umbilical li-
posuction specimens by collagenase dispersion (DM
n53; NDM n145). Isolation efficiency was defined
by number of ASC isolated per gram of adipose tissue.
Proliferation was assessed by constructing growth curves over
14d. ASC were differentiated in endothelial growth medium
for 3wk. Differentiation was determined by measuring EC-
specific gene expression (CD31, vWF) using qPCR. Lastly,
ASC were seeded onto decellularized vein, flow conditioned
from 0-9 dynes over 5d, and examined using confocal
microscopy.
Results: ASC isolation efficiency did not differ be-
tween DM and NDM patients (224,028 cells/gm vs.
259,345 cells/gm, respectively; P  .21). The growth
curves for DM (n6) and NDM (n6) ASC also ap-
peared similar, with no significant differences observed
in cells counts between days 1-14. After 1, 2, and 3wk in
culture, no significant difference in CD31 or vWF ex-
pression between DM (n6) and NDM (n6) cells was
observed. Finally, retention of ASC to vascular scaffolds
under physiological shear stress was similar between the
two groups.
Conclusions: ASC are isolated from diabetics in
quantities similar to non-diabetics. These cells grow at
similar rates, exhibit differentiation into an EC pheno-
type, and line the lumen of a tissue engineered vascular
graft.
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Objectives: Intimal hyperplasia (IH) is the cause of
most failed arterio-venous fistulae (AVF), resulting in
repeat procedures and leading to increased utilization of
scarce health care resources. Our lab has previously demon-
strated the role of supplemental oxygen (O2) in preventing IH
and smooth muscle cell proliferation (SMCp) at an artery to
graft anastomosis and at the deployment site of an intra-
arterial stent. This study is to examine the effect of supplemen-
tal O2 in preventing IH and SMCp at an AVF in a rabbit
model.
Methods: 96 rabbits were randomized into three
groups: Group 1- control; Group 2- AVF without sup-
plemental O2; and Group 3- AVF with supplemental O2.
Rabbits receiving supplemental O2 received 30% oxygen for
Table. Measurement of intimal hyperplasia at fistula sitea
Day 1 Day 21 Day 42 Day 90
GROUP 1 0.02 0.02 0.02 0.02
GROUP 2 0.02 0.103b 0.209b 0.257b
GROUP 3 0.02 0.049 0.033 0.006b
aRatio of area of intima/media
bP.05 when compared to Group 1
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